Stuart Harris
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
- Inflammatory mediators and NSAID effects
-
- Cardiac electrophysiology and arrhythmias
- Atrial Fibrillation Management and Outcomes
Papers in
-
- Inflammatory mediators and NSAID effects 3
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Cardiac electrophysiology and arrhythmias 4
- Co-authors
- Robert S. Balaban (2 shared papers)L. J. Mandel (2 shared papers)Sheldon Preskorn (1 shared paper)Jeffrey Alderman (1 shared paper)Michael Messig (1 shared paper)Menger Chung (1 shared paper)Wilma Harrison (1 shared paper)Lazaro J. Mandel (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (2 papers)Journal of Biological Chemistry (2 papers)Clinical Therapeutics (2 papers)BioDrugs (1 paper)Epilepsy & Behavior (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Stuart Harris
27 papers receiving 856 citations
Peers
Comparison fields: 5 of 101
- Pharmacology 146
- Cardiology and Cardiovascular Medicine 234
- Pharmacology 165
- Nephrology 48
- Psychiatry and Mental health 83
Countries citing papers authored by Stuart Harris
This map shows the geographic impact of Stuart Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Harris more than expected).
Fields of papers citing papers by Stuart Harris
This network shows the impact of papers produced by Stuart Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Harris. The network helps show where Stuart Harris may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Harris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 151 | |
| 2 | 1981 | 139 | |
| 3 | 1996 | 113 | |
| 4 | 2015 | 78 | |
| 5 | 2002 | 56 | |
| 6 | 1995 | 52 | |
| 7 | 1980 | 45 | |
| 8 | 2000 | 44 | |
| 9 | 1998 | 28 | |
| 10 | 1982 | 25 | |
| 11 | 2011 | 21 | |
| 12 | 2020 | 19 | |
| 13 | 2015 | 19 | |
| 14 | 2013 | 17 | |
| 15 | 2004 | 16 | |
| 16 | 1984 | 16 | |
| 17 | 1985 | 14 | |
| 18 | 2014 | 14 | |
| 19 | 2007 | 12 | |
| 20 | 2019 | 12 |
About Stuart Harris
Stuart Harris is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Molecular Biology, Physiology and Pediatrics, Perinatology and Child Health, having authored 27 papers that have together received 923 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (4 papers), Inflammatory mediators and NSAID effects (3 papers), Ion Transport and Channel Regulation (2 papers), Metabolism and Genetic Disorders (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Epilepsy research and treatment (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Pharmacology (146 citations), Cardiology and Cardiovascular Medicine (234 citations), Pharmacology (165 citations), Nephrology (48 citations) and Psychiatry and Mental health (83 citations). Stuart Harris has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Robert S. Balaban, L. J. Mandel, Sheldon Preskorn, Jeffrey Alderman, Michael Messig, Menger Chung, Wilma Harrison, Lazaro J. Mandel, Joel Morganroth and Jeremy N. Ruskin. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Biological Chemistry, Clinical Therapeutics, BioDrugs and Epilepsy & Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.